Skip to main content

NextCure, Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

NXTC$6.27+17.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

NextCure, Inc.

Form 10-Q

For the Quarter Ended June 30, 2025

TABLE OF CONTENTS

​ · ​
​​Page
PART I. FINANCIAL INFORMATION
Item 1.Financial Statements1
​Condensed Balance Sheets as of June 30, 2025 (unaudited) and December 31, 20241
​Unaudited Condensed Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2025 and 20242
​Unaudited Condensed Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2025 and 20243
​Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2025 and 20244
​Notes to Unaudited Condensed Financial Statements5
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations16
Item 3.Quantitative and Qualitative Disclosures about Market Risk25
Item 4.Controls and Procedures25
Part II. OTHER INFORMATION
Item 1.Legal Proceedings26
Item 1A.Risk Factors26
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds26
Item 3.Defaults Upon Senior Securities26
Item 4.Mine Safety Disclosures27
Item 5.Other Information27
Item 6.Exhibits28
SIGNATURES29

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.